ResMed
477 hedge funds and large institutions have $10.2B invested in ResMed in 2019 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 199 increasing their positions, 165 reducing their positions, and 69 closing their positions.
21% more repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 165
0.37% less ownership
Funds ownership: 68.68% → 68.31% (-0.37%)
5% less funds holding
Funds holding: 501 → 477 (-24)
8% less capital invested
Capital invested by funds: $11B → $10.2B (-$872M)
28% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 69
30% less call options, than puts
Call options by funds: $31M | Put options by funds: $44.3M
64% less funds holding in top 10
Funds holding in top 10: 11 → 4 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM Investment Management
Laguna Beach,
California
|
+$282M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$68M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$43.4M |
| 4 |
O
OppenheimerFunds
New York
|
+$35.1M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$28.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$103M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$54.5M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$50.6M |
| 4 |
Renaissance Technologies
New York
|
-$37.9M |
| 5 |
Millennium Management
New York
|
-$35.1M |
RMD Hedge Fund Activity: Q1 2019 in Review
477 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2019, worth a combined $10.2B — down 7.9% from $11B a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of RMD and 50 opened new positions — a net loss of 19 holders — while 165 trimmed existing stakes and 199 added.
The largest buyer was WCM Investment Management, adding an estimated $282M. The largest seller was Fidelity Investments, cutting an estimated $103M.
- 477 institutional investors held ResMed (RMD) as of Q1 2019, down from 501 in Q4 2018.
- Funds reported $10.2B of ResMed stock for Q1 2019, down 7.9% quarter-over-quarter.
- 50 funds opened new ResMed positions in Q1 2019 and 69 closed out, a net change of -19 holders.
- The largest ResMed buyer in Q1 2019 was WCM Investment Management, an estimated $282M added.
- The largest ResMed seller in Q1 2019 was Fidelity Investments, an estimated $103M sold.
Based on aggregated 13F filings for Q1 2019.